Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
30 July 2021Website:
http://www.rxsight.comNext earnings report:
07 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 6 min agoDividend
Analysts recommendations
Institutional Ownership
RXST Latest News
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference.
Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.
RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. (NASDAQ:RXST ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Larry Biegelsen - Wells Fargo Joseph Conway - Needham & Co Rohin Patel - JPMorgan Steven Lichtman - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call.
Today we look at RxSight, Inc., a small ocular focused medical device company focused on transforming the cataract surgery market. The company is delivering 70% year-over-year revenue growth and rapidly expanding its installed base. After a big rally early this summer, the stock has given up a third of its value during the overall selloff in the market that began in August.
After reaching an important support level, RxSight, Inc. (RXST) could be a good stock pick from a technical perspective. RXST surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
RxSight, Inc. (RXST) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.50 per share a year ago.
RxSight, Inc. (RXST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RxSight, Inc. (NASDAQ:RXST ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Participants Allen Gong - JP Morgan Craig Bijou - Bank of America Joseph Conway - Needham & Co. Ryan Zimmerman - BTIG Steven Lichtman - Oppenheimer Lawrence Biegelsen - Wells Fargo Operator Welcome to the RxSight First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
RxSight, Inc. (RXST) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.54 per share a year ago.
What type of business is RxSight?
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
What sector is RxSight in?
RxSight is in the Healthcare sector
What industry is RxSight in?
RxSight is in the Medical Devices industry
What country is RxSight from?
RxSight is headquartered in United States
When did RxSight go public?
RxSight initial public offering (IPO) was on 30 July 2021
What is RxSight website?
https://www.rxsight.com
Is RxSight in the S&P 500?
No, RxSight is not included in the S&P 500 index
Is RxSight in the NASDAQ 100?
No, RxSight is not included in the NASDAQ 100 index
Is RxSight in the Dow Jones?
No, RxSight is not included in the Dow Jones index
When does RxSight report earnings?
The next expected earnings date for RxSight is 07 August 2024